Truvestments Capital’s Zimmer Biomet ZBH Stock Holding History

Truvestments Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16	Closed	-$1K	–	573
2020 Q2	$1K	Buy	+16	New	+$1.84K	﹤0.01%	558
2018 Q3	$4K	Buy	+28	New	+$3.33K	﹤0.01%	765

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Truvestments Capital's ZBH Position: Q3 2020 in Review

Truvestments Capital sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 16 shares — an estimated $1K sold.

Truvestments Capital first reported a position in ZBH in Q3 2018 and held it in 2 quarters. The position peaked at $4K in Q3 2018. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Truvestments Capital reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
Truvestments Capital sold 16 Zimmer Biomet shares in Q3 2020, an estimated $1K.
Truvestments Capital first reported a position in Zimmer Biomet in Q3 2018 and held it in 2 quarters.
Truvestments Capital's Zimmer Biomet position peaked at $4K in Q3 2018.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Truvestments Capital's 13F filing for Q3 2020, filed 13 Nov 2020.